Showing results (181-190 of 293) with videos related to

Sort By:
Pageof 30
Current Pharmaceutical Design|November 28, 2012
From bortezomib to other inhibitors of the proteasome and beyondDaniela Buac, Min Shen, Sara Schmitt, et al.
Pharmaceutical Research|August 29, 2009
Fluorocurcumins as cyclooxygenase-2 inhibitor: molecular docking, pharmacokinetics and tissue distribution in miceSubhash Padhye, Sanjeev Banerjee, Deepak Chavan, et al.
Biological Trace Element Research|March 17, 2012
Association of metals and proteasome activity in erythrocytes of prostate cancer patients and controlsChristine Neslund-Dudas, Bharati Mitra, Ashoka Kandegedara, et al.
Global Change Biology|May 2, 2026
Soil pH Amelioration Fosters Persistent Carbon Sinks Through Mineral Stabilization and Aggregate ProtectionXunzhuo Dong, Bingbing Han, Yunyao Zhong, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 3, 2026
MZF1-mediated GAPDH overexpression drives glycolytic reprogramming and neuroendocrine progression in advanced prostate cancerWang Liu, Lily He, Cuncong Zhong, et al.
Frontiers in Bioscience : a Journal and Virtual Library|March 17, 2005
Synthetic peracetate tea polyphenols as potent proteasome inhibitors and apoptosis inducers in human cancer cellsDeborah Kuhn, Wai Har Lam, Aslamuzzaman Kazi, et al.
Pageof 30